Currently Skimming:
7 Combating Drug-Resistant TB Through PublicPrivate Collaboration and Innovative Approaches
7 Combating Drug-Resistant TB Through PublicPrivate Collaboration and Innovative Approaches
Pages 89-98
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 89... ...
The health care system must address the importance of finding and treating MDR TB patients. Several presenters at the workshop addressed these issues, speaking about Operation ASHA's efforts to provide TB treatment to the many poor and underserved patients in India's slums; ways to engage private-sector providers in broad public campaigns to reduce rates 89
|
From page 90... ...
Because MDR TB treatment takes 2 years and requires continual management, keeping people in the system is a very big challenge, said Batra. Many people in India with MDR TB live in the slums and are highly mobile, returning to villages for events such as marriages or deaths.
|
From page 91... ...
. It has created a dense network of treatment centers for MDR TB near the entry point to the slums, at major bus stops, and near factories so that patients are no more than a 10-minute walk from the nearest center.
|
From page 92... ...
The involvement of governments, NGOs, the private sector, and communities will be essential to meet the challenge. Aggressive cost containment requires the innovative use of technology; the use of low-cost, high-impact community-driven models; and public–private partnerships to deliver MDR TB treatment, said Batra.
|
From page 93... ...
Ambulatory care, human resources, and inpatient care all are dominated by the private sector, and TB care is no different. Two-thirds of India's households rely on private-sector sources for health care (IIPS and Macro International, 2007)
|
From page 94... ...
Beyond the current strategy of exhorting private providers to refer patients to the public sector, two basic approaches have been used to engage and accommodate the private sector in ways that acknowledge and deal with the reality of market forces. First, many countries have tried a collaborative model in which the public sector subsidizes treatments that are then provided by the private sector.
|
From page 95... ...
In India, the availability and use of unaccredited DST and second-line anti-TB drugs are widespread. The provision of subsidized treatment for MDR TB is a powerful incentive, but it is not enough for the RNTCP simply to treat MDR TB.
|
From page 96... ...
A field worker or treatment provider can download data from the server and upload new data on the patient, including basic demographics, laboratory specimens collected, results, whether the patient has MDR TB, and whether the patient is describing any adverse events. This system is an effective and inexpensive tool for health care providers to use when seeing patients in their homes, said Khan.
|
From page 97... ...
The provision of conditional cash transfers via mobile phone resulted in a 100 percent increase in reporting of suspected TB cases to the Indus Hospital TB Program from the first quarter of 2010 to the first quarter of 2011. In addition, support from the Global Fund provides MDR TB patients with monthly food baskets, routine counseling, and other social supports, which serves as an incentive for these patients to complete their treatment.
|
From page 98... ...
• In these innovative programs, the community is utilized, and a divi sion of labor and costs among NGOs, families, foundations, and public and private health care providers is devised to reach more patients and improve treatment.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.